Adipose-specific MTP deficiency protects against hepatic steatosis up upregulating PPARα activity
RNA-seq (gene expression) · mouse · 10 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 5 × hepatocyte_Mttp_flox_CM vs 5 × hepatocyte_Mttp_KO_CMGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Adipose microsomal triglyceride transfer protein deficiency protects against hepatic steatosis by upregulating PPARα activityJHEP reports : innovation in hepatology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE280725_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1180101 and SRA study SRP542230. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 10 samples.
How we read this: 2 replicated groups read from 10 sample titles; they account for 10 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8604929 hepatocyte_Mttp_flox_CM_1 hepatocyte_Mttp_flox_CM
- GSM8604930 hepatocyte_Mttp_flox_CM_2 hepatocyte_Mttp_flox_CM
- GSM8604931 hepatocyte_Mttp_flox_CM_3 hepatocyte_Mttp_flox_CM
- GSM8604932 hepatocyte_Mttp_flox_CM_4 hepatocyte_Mttp_flox_CM
- GSM8604933 hepatocyte_Mttp_flox_CM_5 hepatocyte_Mttp_flox_CM
- GSM8604934 hepatocyte_Mttp_KO_CM_1 hepatocyte_Mttp_KO_CM
- GSM8604935 hepatocyte_Mttp_KO_CM_2 hepatocyte_Mttp_KO_CM
- GSM8604936 hepatocyte_Mttp_KO_CM_3 hepatocyte_Mttp_KO_CM
- GSM8604937 hepatocyte_Mttp_KO_CM_4 hepatocyte_Mttp_KO_CM
- GSM8604938 hepatocyte_Mttp_KO_CM_5 hepatocyte_Mttp_KO_CM
- GSE304787 Therapeutic targeting of lipidated amino acid deficiency ameliorates MASH via a PPARα/CCL2 axis 14 samples shares ppar, deficiency
- GSE288227 Hyodeoxycholic Acid Suppresses Hepatosteatosis via GLP-1/iNKT Cell Crosstalk and PPARα Activation (Bulk RNA-seq) 9 samples shares ppar, steatosis
- GSE268120 The Deubiquitinase USP28 Maintains the Expression of PPARγ and Its Inactivation Protects Mice from Diet-Induced NASH and Hepatocarcinoma 6 samples shares ppar, protects
- GSE288229 Hyodeoxycholic Acid Suppresses Hepatosteatosis via GLP-1/iNKT Cell Crosstalk and PPARα Activation (scRNAseq_CD4+ lymphocytes) 6 samples shares ppar, steatosis
- GSE282998 Comparison of phenotypic and transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse livers 192 samples shares ppar
- GSE314029 An unimolecular GIPR:GLP-1R:PPAR , , quintuple agonist eliminates obesity and insulin resistance in mice. 159 samples shares ppar
- GSE319608 Enhanced antisense oligonucleotide delivery reveals that transcript turnover impacts apparent splicing rescue in myotonic dystrophy 98 samples shares ppar
- GSE302948 Inapparent maternal ZIKV infection impacts fetal brain development and postnatal behavior [BulkSeq] 48 samples shares ppar
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.